vs

Side-by-side financial comparison of Rocky Mountain Chocolate Factory, Inc. (RMCF) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.

Rocky Mountain Chocolate Factory, Inc. is the larger business by last-quarter revenue ($7.5M vs $4.9M, roughly 1.5× Sensus Healthcare, Inc.). Rocky Mountain Chocolate Factory, Inc. runs the higher net margin — -2.1% vs -64.1%, a 62.1% gap on every dollar of revenue. On growth, Rocky Mountain Chocolate Factory, Inc. posted the faster year-over-year revenue change (-4.4% vs -62.2%). Rocky Mountain Chocolate Factory, Inc. produced more free cash flow last quarter ($-1.3M vs $-2.4M). Over the past eight quarters, Rocky Mountain Chocolate Factory, Inc.'s revenue compounded faster (1.9% CAGR vs -31.9%).

Rocky Mountain Chocolate, formerly Rocky Mountain Chocolate Factory, Inc., is an international franchiser, confectionery manufacturer and retail operator in the United States, with outlets in Panama and the Philippines. The company is based in the town of Durango, Colorado, United States of America.

Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.

RMCF vs SRTS — Head-to-Head

Bigger by revenue
RMCF
RMCF
1.5× larger
RMCF
$7.5M
$4.9M
SRTS
Growing faster (revenue YoY)
RMCF
RMCF
+57.8% gap
RMCF
-4.4%
-62.2%
SRTS
Higher net margin
RMCF
RMCF
62.1% more per $
RMCF
-2.1%
-64.1%
SRTS
More free cash flow
RMCF
RMCF
$1.1M more FCF
RMCF
$-1.3M
$-2.4M
SRTS
Faster 2-yr revenue CAGR
RMCF
RMCF
Annualised
RMCF
1.9%
-31.9%
SRTS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
RMCF
RMCF
SRTS
SRTS
Revenue
$7.5M
$4.9M
Net Profit
$-155.0K
$-3.2M
Gross Margin
34.0%
38.4%
Operating Margin
1.1%
-63.8%
Net Margin
-2.1%
-64.1%
Revenue YoY
-4.4%
-62.2%
Net Profit YoY
81.7%
-304.9%
EPS (diluted)
$-0.02
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMCF
RMCF
SRTS
SRTS
Q4 25
$7.5M
$4.9M
Q3 25
$6.8M
$6.9M
Q2 25
$6.4M
$7.3M
Q1 25
$8.9M
$8.3M
Q4 24
$7.9M
$13.1M
Q3 24
$6.4M
$8.8M
Q2 24
$6.4M
$9.2M
Q1 24
$7.3M
$10.7M
Net Profit
RMCF
RMCF
SRTS
SRTS
Q4 25
$-155.0K
$-3.2M
Q3 25
$-662.0K
$-943.0K
Q2 25
$-324.0K
$-1.0M
Q1 25
$-2.9M
$-2.6M
Q4 24
$-847.0K
$1.5M
Q3 24
$-722.0K
$1.2M
Q2 24
$-1.7M
$1.6M
Q1 24
$-1.6M
$2.3M
Gross Margin
RMCF
RMCF
SRTS
SRTS
Q4 25
34.0%
38.4%
Q3 25
23.6%
39.4%
Q2 25
31.1%
39.7%
Q1 25
10.8%
52.2%
Q4 24
23.4%
54.4%
Q3 24
31.8%
59.3%
Q2 24
12.8%
58.7%
Q1 24
24.3%
62.5%
Operating Margin
RMCF
RMCF
SRTS
SRTS
Q4 25
1.1%
-63.8%
Q3 25
-7.0%
-37.3%
Q2 25
-2.3%
-26.6%
Q1 25
-30.3%
-31.7%
Q4 24
-8.9%
13.2%
Q3 24
-14.3%
16.9%
Q2 24
-25.4%
21.5%
Q1 24
-21.7%
27.1%
Net Margin
RMCF
RMCF
SRTS
SRTS
Q4 25
-2.1%
-64.1%
Q3 25
-9.7%
-13.7%
Q2 25
-5.1%
-14.2%
Q1 25
-32.5%
-30.8%
Q4 24
-10.7%
11.8%
Q3 24
-11.3%
13.7%
Q2 24
-25.9%
17.4%
Q1 24
-21.9%
21.3%
EPS (diluted)
RMCF
RMCF
SRTS
SRTS
Q4 25
$-0.02
$-0.19
Q3 25
$-0.09
$-0.06
Q2 25
$-0.04
$-0.06
Q1 25
$-0.38
$-0.16
Q4 24
$-0.11
$0.10
Q3 24
$-0.11
$0.07
Q2 24
$-0.26
$0.10
Q1 24
$-0.25
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMCF
RMCF
SRTS
SRTS
Cash + ST InvestmentsLiquidity on hand
$641.0K
$22.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$6.0M
$48.1M
Total Assets
$20.7M
$53.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMCF
RMCF
SRTS
SRTS
Q4 25
$641.0K
$22.1M
Q3 25
$2.0M
$24.5M
Q2 25
$893.0K
$22.2M
Q1 25
$720.0K
$19.1M
Q4 24
$1.1M
$22.1M
Q3 24
$973.0K
$22.6M
Q2 24
$637.0K
$19.0M
Q1 24
$2.1M
$14.7M
Stockholders' Equity
RMCF
RMCF
SRTS
SRTS
Q4 25
$6.0M
$48.1M
Q3 25
$6.1M
$51.2M
Q2 25
$6.7M
$52.1M
Q1 25
$7.0M
$53.0M
Q4 24
$9.8M
$55.8M
Q3 24
$10.5M
$54.1M
Q2 24
$9.0M
$52.9M
Q1 24
$10.6M
$51.2M
Total Assets
RMCF
RMCF
SRTS
SRTS
Q4 25
$20.7M
$53.0M
Q3 25
$22.3M
$58.3M
Q2 25
$20.1M
$58.9M
Q1 25
$21.2M
$60.2M
Q4 24
$21.6M
$62.2M
Q3 24
$21.1M
$59.9M
Q2 24
$19.0M
$58.2M
Q1 24
$20.6M
$57.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMCF
RMCF
SRTS
SRTS
Operating Cash FlowLast quarter
$-1.2M
$-2.2M
Free Cash FlowOCF − Capex
$-1.3M
$-2.4M
FCF MarginFCF / Revenue
-16.9%
-47.9%
Capex IntensityCapex / Revenue
0.5%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$332.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMCF
RMCF
SRTS
SRTS
Q4 25
$-1.2M
$-2.2M
Q3 25
$-488.0K
$2.3M
Q2 25
$350.0K
$3.1M
Q1 25
$1.2M
$-2.7M
Q4 24
$-2.1M
$-827.0K
Q3 24
$-3.5M
$4.0M
Q2 24
$-2.2M
$4.2M
Q1 24
$129.0K
$-8.2M
Free Cash Flow
RMCF
RMCF
SRTS
SRTS
Q4 25
$-1.3M
$-2.4M
Q3 25
$-544.0K
$2.3M
Q2 25
$182.0K
$3.1M
Q1 25
$-2.7M
Q4 24
$-1.1M
Q3 24
$-4.6M
$3.6M
Q2 24
$-2.6M
$4.2M
Q1 24
$-352.3K
$-8.4M
FCF Margin
RMCF
RMCF
SRTS
SRTS
Q4 25
-16.9%
-47.9%
Q3 25
-8.0%
33.3%
Q2 25
2.9%
42.2%
Q1 25
-32.2%
Q4 24
-8.6%
Q3 24
-72.6%
40.9%
Q2 24
-40.2%
45.8%
Q1 24
-4.9%
-79.0%
Capex Intensity
RMCF
RMCF
SRTS
SRTS
Q4 25
0.5%
3.2%
Q3 25
0.8%
0.1%
Q2 25
2.6%
0.4%
Q1 25
0.1%
Q4 24
2.3%
Q3 24
17.5%
3.8%
Q2 24
6.5%
0.0%
Q1 24
6.6%
2.2%
Cash Conversion
RMCF
RMCF
SRTS
SRTS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.53×
Q3 24
3.25×
Q2 24
2.62×
Q1 24
-3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMCF
RMCF

Manufacturing$5.9M78%
Transferred At Point In Time$1.2M16%
Other$414.0K5%

SRTS
SRTS

Products$2.8M57%
Other$2.1M43%

Related Comparisons